Skip to main content

Table 3 Multivariate analysis of risk factors associated with new vertebral fractures

From: Incidence and predictors of morphometric vertebral fractures in patients with ankylosing spondylitis

Variable Total AS patients AS patients without baseline VFs
  (n = 298) (n = 268)
  Odds ratio 95% CI P-value Odds ratio 95% CI P-value
TNF inhibitor       
Baseline VF 12.8 3.6 to 45.3 <0.001    
HLA-B27       
Uveitis       
SASSS progression       
CRP increase 5.4 1.7 to 17.7 0.005 4.8 1.4 to 15.9 0.011
  1. AS, ankylosing spondylitis; TNF, tumor necrosis factor; SASSS, Stokes ankylosing spondylitis spine score; CRP, C-reactive protein.